The T cell factor/β-Catenin Antagonist PKF115–584 Inhibits Proliferation of Adrenocortical Carcinoma Cells
Open Access
- 1 August 2008
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 93 (8) , 3222-3225
Abstract
Context: Mutations of the β-catenin (CTNNB1) gene are frequently found in adrenocortical tumors. This has important consequences to deregulate the expression of transcriptional targets of the Wnt pathway, which may contribute to tumorigenesis. Objective: The objective of the study was to investigate the effect of the small-molecule inhibitor of the T cell factor (Tcf)/β-catenin complex PKF115–584 on β-catenin-dependent transcription and proliferation of H295R adrenocortical tumor cells, which harbor mutations in CTNNB1 as well as the TP53 tumor suppressor gene. Main Outcome Measures: Immunofluorescence, transient transfection, proliferation assays, and flow cytometric analyses were used. Results: Nuclear localization of β-catenin and constitutive activation of β-catenin-dependent transcription was observed in H295R cells. PKF115–584 dose-dependently inhibited β-catenin-dependent transcription and H295R proliferation, even in the presence of increased steroidogenic factor-1 levels, which augment proliferation in this cell line. The drug had no effect on HeLa cells, a cell line in which the β-catenin pathway is not activated. PKF115–584 decreased the percentage of H295R cells in S-phase and increased the percentage of apoptotic cells. Conclusions: Inhibitors of the Tcf/β-catenin complex may prove useful in the treatment of adrenocortical tumors in which multiple genetic alterations have accumulated.Keywords
This publication has 13 references indexed in Scilit:
- Increased Steroidogenic Factor-1 Dosage Triggers Adrenocortical Cell Proliferation and CancerMolecular Endocrinology, 2007
- Adrenal Gland Tumorigenesis after Gonadectomy in Mice Is a Complex Genetic Trait Driven by Epistatic LociEndocrinology, 2007
- Nephroblastoma Overexpressed/Cysteine-Rich Protein 61/Connective Tissue Growth Factor/Nephroblastoma Overexpressed Gene-3 (NOV/CCN3), a Selective Adrenocortical Cell Proapoptotic Factor, Is Down-Regulated in Childhood Adrenocortical TumorsThe Journal of Clinical Endocrinology & Metabolism, 2007
- WNT Signaling Pathway and Stem Cell Signaling NetworkClinical Cancer Research, 2007
- Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myelomaProceedings of the National Academy of Sciences, 2007
- Mutations of β-Catenin in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical TumorsCancer Research, 2005
- Gonadotropin-Induced Adrenocortical Neoplasia in NU/J Nude MiceEndocrinology, 2005
- Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complexCancer Cell, 2004
- Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphonyTrends in Endocrinology & Metabolism, 2003
- The Molecular Pathogenesis of Hereditary and Sporadic Adrenocortical and Adrenomedullary TumorsThe Journal of Clinical Endocrinology & Metabolism, 2002